Chemistry Group specialized in the design and engineering of synthetic routes toward hard to make active molecules for Healthcare applications. M2I holds a portfolio of proprietary DMFs and has already successfully applied its nonconventional retrosynthetic approach of active ingredients, using continuous flow to solve important quality and stability issues. M2I also develops pheromones based solutions for crop protection and animal health.
M2I - Melchior Investissements et Industries
1 rue Royale
Bureaux de la Colline